Renal responses to three types of renin–angiotensin system blockers in patients with diabetes mellitus on a high-salt diet

Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study

(2011) Subodh Verma et al.   EUROPEAN HEART JOURNAL

Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial

(2010) F. Persson et al.   DIABETOLOGIA

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria

(2009) F. Persson et al.   DIABETES CARE

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design

(2009) H.-H. Parving et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Aliskiren-Binding Increases the Half Life of Renin and Prorenin in Rat Aortic Vascular Smooth Muscle Cells

(2008) Wendy W. Batenburg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans

(2008) Naomi D.L. Fisher et al.   CIRCULATION

Aliskiren Accumulates in Renin Secretory Granules and Binds Plasma Prorenin

(2008) Manne Krop et al.   HYPERTENSION

The Renin Rise With Aliskiren: It’s Simply Stoichiometry

(2008) A. H. Jan Danser et al.   HYPERTENSION

Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors

(2008) Maarten ADH Schalekamp et al.   JOURNAL OF HYPERTENSION

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

(2008) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation

(2006) Joep H M Esch et al.   BRITISH JOURNAL OF PHARMACOLOGY